Epstein-Barr virus early antigen diffuse (EBV-EA/D)-directed immunoglobulin A antibodies in systemic lupus erythematosus patients.
about
Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and rheumatoid arthritisEpstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causationAutoimmunity and the gutReduced response to Epstein-Barr virus antigens by T-cells in systemic lupus erythematosus patients.Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patientsIsotypes of Epstein-Barr virus antibodies in rheumatoid arthritis: association with rheumatoid factors and citrulline-dependent antibodiesElevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.Impaired Cytokine Responses to Epstein-Barr Virus Antigens in Systemic Lupus Erythematosus PatientsEpstein-Barr virus in systemic autoimmune diseasesDeficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome.High seroprevalence of human herpesvirus 8 infection in patients with systemic lupus erythematosus.The Possible Effect of B-Cell Epitopes of Epstein–Barr Virus Early Antigen, Membrane Antigen, Latent Membrane Protein-1, and -2A on Systemic Lupus Erythematosus.Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.Epstein-Barr virus and systemic lupus erythematosus
P2860
Q26785341-6800EE0F-A691-48D3-BA9B-4ECBBEC38163Q26830464-78A0685E-1122-452F-B851-465FA3FD0CEAQ33676951-488AB593-21BB-45E3-A0A6-B6F6F23F0849Q34478829-FED54DDE-7FE4-4BDC-846A-807310CD32E9Q35317749-9AA3FB8F-F8A0-4855-AE6F-4B8D1C27988EQ35591973-F70463FE-4420-47B4-932C-6C8325E2270DQ35786726-E4453F57-DB02-42B6-8FE9-CDE978CCE1A9Q36399124-34F1C6CD-6F6A-4DC9-BE50-AF3F31882E6CQ36784009-3CE411DE-E124-4057-B445-F847FB283CEBQ37154847-C832B3B2-7503-46D6-88FB-0E0372B3704EQ37484088-B80D12F7-8B06-4849-8337-CCDFF510E003Q42252634-27960394-B299-477B-8571-3D460DDA4D07Q50347150-157422E6-882E-4A2B-AA11-F44EA2C9376EQ54264121-5664DFE9-E224-4592-963F-985D9ADEE956Q58908905-04C9BD43-FF25-4F58-95FC-FD5ACA53DACD
P2860
Epstein-Barr virus early antigen diffuse (EBV-EA/D)-directed immunoglobulin A antibodies in systemic lupus erythematosus patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Epstein-Barr virus early antig ...... lupus erythematosus patients.
@en
Epstein-Barr virus early antigen diffuse
@nl
type
label
Epstein-Barr virus early antig ...... lupus erythematosus patients.
@en
Epstein-Barr virus early antigen diffuse
@nl
prefLabel
Epstein-Barr virus early antig ...... lupus erythematosus patients.
@en
Epstein-Barr virus early antigen diffuse
@nl
P2093
P2860
P1476
Epstein-Barr virus early antig ...... c lupus erythematosus patients
@en
P2093
A H Draborg
C T Nielsen
E Theander
J M Jørgensen
L P Nielsen
L V Iversen
P2860
P304
P356
10.3109/03009742.2012.665944
P577
2012-05-31T00:00:00Z